Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,043 | -19,706 | -76,408 | -54,277 | -35,765 |
| Depreciation Amortization | 619 | 306 | 1,295 | 971 | 628 |
| Accounts payable and accrued liabilities | -517 | 23 | -1,040 | -1,497 | -2,382 |
| Other Working Capital | -5,078 | -6,803 | 4,441 | 2,407 | 1,599 |
| Other Operating Activity | 4,439 | 1,728 | 7,865 | 5,936 | 4,863 |
| Operating Cash Flow | $-40,580 | $-24,452 | $-63,847 | $-46,460 | $-31,057 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,850 | 9,484 | -113,254 | -23,451 | -45,170 |
| PPE Investments | -613 | -88 | -709 | -392 | -302 |
| Investing Cash Flow | $29,237 | $9,396 | $-113,963 | $-23,843 | $-45,472 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 336 | 253 | 97,290 | 4,305 | 2,679 |
| Financing Cash Flow | $336 | $253 | $97,290 | $4,305 | $2,679 |
| Beginning Cash Position | 41,850 | 41,850 | 122,370 | 122,370 | 122,370 |
| End Cash Position | 30,843 | 27,047 | 41,850 | 56,372 | 48,520 |
| Net Cash Flow | $-11,007 | $-14,803 | $-80,520 | $-65,998 | $-73,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,580 | -24,452 | -63,847 | -46,460 | -31,057 |
| Capital Expenditure | -613 | -88 | -709 | -392 | -302 |
| Free Cash Flow | -41,193 | -24,540 | -64,556 | -46,852 | -31,359 |